Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?
- PMID: 31020699
- DOI: 10.1002/ana.25493
Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
